Publications | Lund University Publications

11 – 20 of 31

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Rituximab%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2020
Mark Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
Felberg, Anna ; Taszner, Michał ; Urban, Aleksandra ; Majeranowski, Alan ; Jaskuła, Kinga ; Jurkiewicz, Aleksandra ; Stasiłojć, Grzegorz ; Blom, Anna M. ^LU ; Zaucha, Jan M. and Okrój, Marcin ^LU (2020) In Frontiers in Immunology 11.
- Contribution to journal › Article
Mark Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler, Philipp ; Shin, Jae Il ; Alberici, Federico ; Audard, Vincent ; Bruchfeld, Annette ; Busch, Martin ; Cheung, Chee Kay ; Crnogorac, Matija ; Delbarba, Elisa and Eller, Kathrin , et al. (2020) In Autoimmunity Reviews 19(11).
- Contribution to journal › Scientific review
2019
Mark Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
Elhai, Muriel ; Boubaya, Marouane ; Distler, Oliver ; Smith, Vanessa ; Matucci-Cerinic, Marco ; Alegre Sancho, Juan José ; Truchetet, Marie Elise ; Braun-Moscovici, Yolanda ; Iannone, Florenzo and Novikov, Pavel I. , et al. (2019) In Annals of the Rheumatic Diseases 78(7). p.979-987
- Contribution to journal › Article
Mark Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
Felberg, Anna ; Urban, Aleksandra ; Borowska, Anna ; Stasiłojć, Grzegorz ; Taszner, Michał ; Hellmann, Andrzej ; Blom, Anna Maria ^LU and Okrój, Marcin ^LU (2019) In Cancer Immunology, Immunotherapy 68(4). p.587-598
- Contribution to journal › Article
Mark Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Teixeira, Vitor ; Mohammad, Aladdin J. ^LU ; Jones, Rachel B. ; Smith, Rona and Jayne, David (2019) In RMD Open 5(1).
- Contribution to journal › Article
Mark Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
Frisell, Thomas ; Dehlin, Mats ; Di Giuseppe, Daniela ; Feltelius, Nils ; Turesson, Carl ^LU and Askling, Johan (2019) In Rheumatology (United Kingdom) 58(8). p.1367-1377
- Contribution to journal › Article
2018
Mark Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Dang, Nam H. ; Ogura, Michinori ; Castaigne, Sylvie ; Fayad, Luis E. ; Jerkeman, Mats ^LU ; Radford, John ; Pezzutto, Antonio ; Bondarenko, Igor N. ; Stewart, Douglas A. and Shnaidman, Michael , et al. (2018) In British Journal of Haematology 182(4). p.583-586
- Contribution to journal › Debate/Note/Editorial
Mark Mantle cell lymphoma strategies in primary treatment
Albertsson Lindblad, Alexandra ^LU (2018) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2018(28).
- Thesis › Doctoral thesis (compilation)
2017
Mark Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014 : An analysis of the Swedish Lymphoma Registry
Molin, Daniel ; Linderoth, Johan ^LU and Wahlin, Björn Engelbrekt (2017) In British Journal of Haematology 177(3). p.449-456
- Contribution to journal › Article
Mark Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
Einarsson, Jon Thorkell ^LU ; Evert, Max ; Geborek, Pierre ^LU ; Saxne, Tore ^LU ; Lundgren, Maria ^LU and Kapetanovic, Meliha C. ^LU (2017) In Clinical Rheumatology 36(12). p.2743-2750
- Contribution to journal › Article

your query:: Remove keywords: Rituximab